Adjuvant Trial Organisation.

Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer. 'Nolvadex' Adjuvant Trial Organisation.

Analysis at Eight Years by 'Nolvadex', Adjuvant Trial Organisation., A. T. Organisation., 1988, British Journal of Cancer.